Polyneuropathy associated with IgM monoclonal gammopathy with anti-MAG Advocacy Hub | UniteRare

At a Glance

Live from database

🔬

1Recruiting trials

🩺

3Specialists

Regulatory Watchboard

1 event

Jun 2023Rituximab Therapy in Anti-Myelin Associated Glycoprotein Patients With Characteristics of Good Responders

Centre Hospitalier Universitaire de Saint Etienne — PHASE3

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Polyneuropathy associated with IgM monoclonal gammopathy with anti-MAG.
Check the disease page for updates →

Clinical Trial Landscape

1 active trial

1Phase 3

1Total recruiting

Search clinical trials for Polyneuropathy associated with IgM monoclonal gammopathy with anti-MAG →

Recent News & Research

No recent news articles indexed yet for Polyneuropathy associated with IgM monoclonal gammopathy with anti-MAG.
Search PubMed for Polyneuropathy associated with IgM monoclonal gammopathy with anti-MAG →

Browse all Polyneuropathy associated with IgM monoclonal gammopathy with anti-MAG news →

Specialist Network

Top 3 by expertise

Jean-Marc LEGER, MD

Hôpital de la Pitié Salpêtrière - Paris 75013

Score 242 trials

Nathalie KUBIS

Physiology Department, Lariboisière Hospital

Score 02 trials

Anne-Laure KAMINSKY

CHU de Saint-Etienne

Score 01 trial

View all Polyneuropathy associated with IgM monoclonal gammopathy with anti-MAG specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰